Impact of estradiol on insulin signaling in the rat heart

Cell Biochemistry and Function

Volumn 27, Issue 2, 2009, Pages 102-110

  Koricanac, Goran ^a   Milosavljevic, Tijana ^a   Stojiljkovic, Mojca ^a   Zakula, Zorica ^a   Tepavcevic, Snezana ^a   Ribarac Stepic, Nevena ^a   Isenovic, Esma R ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

17 estradiol; Akt; Heart; Insulin receptor; Insulin signaling; PI3 kinase

Indexed keywords

ESTRADIOL; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85; TYROSINE; FATTY ACID; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, RAT; IRS2 PROTEIN, RAT;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HEART; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; DRUG EFFECT; GENETICS; HEART MUSCLE; METABOLISM; OVARIECTOMY; PHYSIOLOGY; SWINE; WISTAR RAT;

RATTUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOOD GLUCOSE; ESTRADIOL; FATTY ACIDS, NONESTERIFIED; FEMALE; HEART; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; MYOCARDIUM; OVARIECTOMY; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; SWINE;

EID: 63149148931     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1542     Document Type: Article

References (53)

1. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006; 7: 85-96. DOI: 10.1038/nrm1837
2. Velloso LA, Carvalho CR, Rojas FA, Folli F, Saad MJ. Insulin signalling in heart involves insulin receptor substrates-1 and -2, activation of phosphatidylinositol 3-kinase and the JAK 2-growth related pathway. Cardiovasc Res 1998; 40: 96-102. DOI: 10.1016/ S0008-6363(98)00098-4
3. Algenstaedt P, Antonetti DA, Yaffe MB, Kahn CR. Insulin receptor substrate proteins create a link between the tyrosine phosphorylation cascade and the Ca2+-ATPases in muscle and heart. J Biol Chem 1997; 272: 23696-23702.
4. Thirone AC, Huang C, Klip A. Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends Endocrinol Metab 2006; 17: 72-78. DOI: 10.1016/j.tem.2006.01.005
5. Eckel J, Reinauer H. Characteristics of insulin receptors in the heart muscle: binding of insulin to isolated muscle cells from adult rat heart. Biochim Biophys Acta 1980; 629: 510-521. DOI: 10.1016/0304-4165(80)90156-7
6. Laustsen PG, Russell SJ, Cui L, et al. Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Mol Cell Biol 2007; 27: 1649-1664. DOI: 10.1128/MCB.01110-06
7. Shiojima I, Yefremashvili M, Luo Z, et al. Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J Biol Chem 2002; 277: 37670-37677. DOI: 10.1074/ jbc.M204572200
8. Matsui T, Nagoshi T, Rosenzweig A. Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival. Cell Cycle 2003; 2: 220-223.
9. Shioi T, Kang PM, Douglas PS, et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. Embo J 2000; 19: 2537-2548. DOI: 10.1093/emboj/19.11.2537
10. Matsui T, Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 2005; 38: 63-71. DOI: 10.1016/ j.yjmcc.2004.11.005
11. Naga Prasad SV, Perrino C, Rockman HA. Role of phosphoinositide 3-kinase in cardiac function and heart failure. Trends Cardiovasc Med 2003; 13: 206-212. DOI: 10.1016/S1050-1738(03)00080-X
12. Abel ED. Insulin signaling in heart muscle: lessons from genetically engineered mouse models. Curr Hypertens Rep 2004; 6: 416-423.
13. Brownsey RW, Boone AN, Allard MF. Actions of insulin on the mammalian heart: metabolism, pathology and biochemical mechanisms. Cardiovasc Res 1997; 34: 3-24. DOI: 10.1016/S0008-6363(97)00051-5
14. Belke DD, Betuing S, Tuttle MJ, et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 2002; 109: 629-639. DOI: 10.1172/JCI0213946
15. Abel ED. Glucose transport in the heart. Front Biosci 2004; 9: 201-215.
16. Gao F, Gao E, Yue TL, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002; 105: 1497-1502. DOI: 10.1161/01.CIR. 0000012529.00367.0F
17. Abel ED. Myocardial insulin resistance and cardiac complications of diabetes. Curr Drug Targets Immune Endocr Metabol Disord 2005; 5: 219-226. DOI: 10.2174/1568008054064869
18. Barros RP, Machado UF, Gustafsson JA. Estrogen receptors: new players in diabetes mellitus. Trends Mol Med 2006; 12: 425-431. DOI:10.1016/j.molmed.2006.07.004
19. Liu ML, Xu X, Rang WQ, Li YJ, Song HP. Influence of ovariectomy and 17beta-estradiol treatment on insulin sensitivity, lipid metabolism and post-ischemic cardiac function. Int J Cardiol 2004; 97: 485-493. DOI: 10.1016/j. ijcard.2003.11.046
20. Patten RD, Pourati I, Aronovitz MJ, et al. 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phosphoinositide-3 kinase/Akt signaling. Circ Res 2004; 95: 692-699. DOI: 10.1161/01.RES.0000144126.57786.89
21. Gonzalez C, Alonso A, Grueso NA, Esteban MM, Fernandez S, Patterson AM. Effect of treatment with different doses of 17-beta-estradiol on the insulin receptor. Life Sci 2002; 70: 1621-1630. DOI: 10.1016/S0024-3205(02)01489-3
22. Liu ML, Xu X, Xie P, et al. Effects of long-term estrogen replacement treatment on the blood pressure and expression of IR and IRS-1 in myocardium. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2005; 30: 38-40.
23. Koricanac G, Milosavljevic T, Stojiljkovic M, Zakula Z, Ribarac-Stepic N, Isenovic ER. Insulin signaling in the liver and uterus of ovariectomized rats treated with estradiol. J Steroid Biochem Mol Biol 2008; 108: 109-116. DOI: 10.1016/j.jsbmb.2007.06.001
24. Monti LD, Landoni C, Setola E, et al. Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients. Am J Physiol Heart Circ Physiol 2004; 287: H1225-H1231. DOI: 10.1152/ ajpheart.00629.2003
25. Davidoff AJ. Convergence of glucose- and fatty acid-induced abnormal myocardial excitation-contraction coupling and insulin signalling. Clin Exp Pharmacol Physiol 2006; 33: 152-158. DOI: 10.1111/ j.1440-1681.2006.04343.x
26. Kim JK, Levin ER. Estrogen signaling in the cardiovascular system. Nucl Recept Signal 2006; 4: e013. DOI: 10.1621/nrs.04013
27. Patten RD, Karas RH. Estrogen replacement and cardiomyocyte protection. Trends Cardiovasc Med 2006; 16: 69-75. DOI: 10.1016/ j.tcm.2006.01.002
28. Garcia-Arencibia M, Davila N, Campion J, Carmen Carranza M, Calle C. Identification of two functional estrogen response elements complexed with AP-1-like sites in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 2005; 94: 1-14. DOI: 10.1016/ j.jsbmb.2004.12.020
29. Garcia-Arencibia M, Molero S, Davila N, Carranza MC, Calle C. 17beta-Estradiol transcriptionally represses human insulin receptor gene expression causing cellular insulin resistance. Leuk Res 2005; 29: 79-87. DOI: 10.1016/j.leukres.2004.05.012
30. Panno ML, Mauro L, Marsico S, et al. Evidence that the mouse insulin receptor substrate-1 belongs to the gene family on which the promoter is activated by estrogen receptor alpha through its interaction with Sp1. J Mol Endocrinol 2006; 36: 91-105. DOI: 10.1677/ jme.1.01848
31. Richards RG, DiAugustine RP, Petrusz P, Clark GC, Sebastian J. Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in the uterus. Proc Natl Acad Sci USA 1996; 93: 12002-12007.
32. Richards RG, Klotz DM, Bush MR,Walmer DK, DiAugustine RP. E2-induced degradation of uterine insulin receptor substrate-2: requirement for an IGF-I-stimulated, proteasome-dependent pathway. Endocrinology 2001; 142: 3842-3849.
33. Richards RG, Walker MP, Sebastian J, DiAugustine RP. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse. J Biol Chem 1998; 273: 11962-11969.
34. Giorgino F, Logoluso F, Davalli AM, et al. Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats. Diabetes 1999; 48: 801-812.
35. Duncombe WG. The colorimetric micro-determination of non-esterified fatty acids in plasma. Clin Chim Acta 1964; 9: 122-125.
36. Dupont J, Derouet M, Simon J, Taouis M. Nutritional state regulates insulin receptor and IRS-1 phosphorylation and expression in chicken. Am J Physiol 1998; 274: E309-E316.
37. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685. DOI: 10.1038/227680a0
38. Toba H, Gomyo E, Miki S, et al. Hyperinsulinaemia increases the gene expression of endothelial nitric oxide synthase and the phosphatidylinositol 3-kinase/Akt pathway in rat aorta. Clin Exp Pharmacol Physiol 2006; 33: 440-447. DOI: 10.1111/ j.1440-1681.2006.04385.x
39. Knuuti MJ, Maki M, Yki-Jarvinen H, et al. The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol 1995; 27: 1359-1367. DOI: 10.1006/jmcc.1995.0129
40. Wiggers H, Norrelund H, Nielsen SS, et al. Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium. Am J Physiol Heart Circ Physiol 2005; 289: H938-H946. DOI: 10.1152/ ajpheart.00150.2005
41. Song D, Arikawa E, Galipeau DM, et al. Chronic estrogen treatment modifies insulin-induced insulin resistance and hypertension in ovariectomized rats. Am J Hypertens 2005; 18: 1189-1194. DOI: 10.1016/j.amjhyper.2005.04.003
42. Barros RP, Morani A, Moriscot A, Machado UF. Insulin resistance of pregnancy involves estrogen-induced repression of muscle GLUT4. Mol Cell Endocrinol 2008; 295: 24-31. doi:10.1016/ j.mce.2008.07.008
43. Sutter-Dub MT. Rapid non-genomic and genomic responses to progestogens, estrogens, and glucocorticoids in the endocrine pancreatic B cell, the adipocyte and other cell types. Steroids 2002; 67: 77-93. doi:10.1016/S0039-128X(01)00142-8
44. Godsland IF. Oestrogens and insulin secretion. Diabetologia 2005; 48: 2213-2220. DOI:10.1007/s00125-005-1930-0
45. Van Pelt RE, Gozansky WS, Schwartz RS, Kohrt WM. Intravenous estrogens increase insulin clearance and action in postmenopausal women. Am J Physiol Endocrinol Metab 2003; 285: E311-E317. doi:10.1152/ ajpendo.00490.2002
46. Campbell SE, Febbraio MA. Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am J Physiol Endocrinol Metab 2002; 282: E1139-E1146. doi:10.1152/ajpendo. 00184.2001
47. Jensen MD, Martin ML, Cryer PE, Roust LR. Effects of estrogen on free fatty acid metabolism in humans. Am J Physiol 1994; 266: E914-E920.
48. Louet JF, LeMay C, Mauvais-Jarvis F. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 2004; 6: 180-185.
49. Takeda-Matsubara Y, Nakagami H, Iwai M, et al. Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II. Hypertension 2002; 39: 41-45. DOI: 10.1161/hy1201.097197
50. Morelli C, Garofalo C, Bartucci M, Surmacz E. Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells. Oncogene 2003; 22: 4007-4016. DOI: 10.1038/sj.onc.1206436
51. Morelli C, Garofalo C, Sisci D, et al. Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters. Oncogene 2004; 23: 7517-7526. DOI: 10.1038/sj.onc.1208014
52. Ren J, Hintz KK, Roughead ZK, et al. Impact of estrogen replacement on ventricular myocyte contractile function and protein kinase B/Akt activation. Am J Physiol Heart Circ Physiol 2003; 284: H1800-H1807. DOI: 10.1152/ajpheart.00866.2002
53. Sovershaev MA, Egorina EM, Andreasen TV, Jonassen AK, Ytrehus K. Preconditioning by 17beta-estradiol in isolated rat heart depends on PI3-K/PKB pathway, PKC, and ROS. Am J Physiol Heart Circ Physiol 2006; 291: H1554-H1562. DOI: 10.1152/ajpheart.01171.2005